FDA Grants Priority Review to Eylea HD for Macular Edema Following RVO
QUASAR Phase III study data show higher-dose aflibercept could reduce injection frequency for retinal vein occlusion patients. Bayer (Leverkusen, Germany)…
QUASAR Phase III study data show higher-dose aflibercept could reduce injection frequency for retinal vein occlusion patients. Bayer (Leverkusen, Germany)…
![[Internal] Newsroom Researchers Develop Head Mounted Robotic System for Retinal Surgery (1)](https://piemagazine.org/wp-content/uploads/sites/4/2025/02/Internal-Newsroom-Researchers-Develop-Head-Mounted-Robotic-System-for-Retinal-Surgery-1-579x326.png)
